Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Etanercept provides a more physiological approach in the treatment of psoriasis.
Altomare G, Ayala F, Berardesca E, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P, Peserico A, Guerra AP, Vena GA. Altomare G, et al. Among authors: peserico a. Dermatol Ther. 2008 Oct;21 Suppl 2:S1-14. doi: 10.1111/j.1529-8019.2008.00226.x. Dermatol Ther. 2008. PMID: 18837727 Review.
Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system.
de Portu S, Del Giglio M, Altomare G, Arcangeli F, Berardesca E, Calzavara-Pinton P, Lotti T, Martini P, Peserico A, Simonacci M, Vena GA, Girolomoni G. de Portu S, et al. Among authors: peserico a. Dermatol Ther. 2010 Jan-Feb;23 Suppl 1:S7-13. doi: 10.1111/j.1529-8019.2009.01280.x. Dermatol Ther. 2010. PMID: 20136921
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.
Girolomoni G, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Peserico A, Puglisi Guerra A, Vena GA. Girolomoni G, et al. Among authors: peserico a. Immunopharmacol Immunotoxicol. 2012 Aug;34(4):548-60. doi: 10.3109/08923973.2011.653646. Epub 2012 Feb 2. Immunopharmacol Immunotoxicol. 2012. PMID: 22296031 Review.
Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs".
Spandonaro F, Ayala F, Berardesca E, Chimenti S, Girolomoni G, Martini P, Peserico A, Polistena B, Guerra AP, Vena GA, Altomare G, Pinton PC. Spandonaro F, et al. Among authors: peserico a. BioDrugs. 2015 Feb;29(1):71-2. doi: 10.1007/s40259-015-0118-5. BioDrugs. 2015. PMID: 25647521 Free article. No abstract available.
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database.
Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P, Mazzaglia G, Peserico A, Puglisi Guerra A, Sini G, Cassano N, Cricelli C. Vena GA, et al. Among authors: peserico a. Eur J Dermatol. 2010 Sep-Oct;20(5):593-8. doi: 10.1684/ejd.2010.1017. Epub 2010 Jul 7. Eur J Dermatol. 2010. PMID: 20605768
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A, Chimenti S. Saraceno R, et al. Among authors: peserico a. J Dermatolog Treat. 2007;18(6):361-5. doi: 10.1080/09546630701646156. J Dermatolog Treat. 2007. PMID: 17934937 Clinical Trial.
234 results